Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We herewith enclose the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended March 31, 2022 received from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company. Metropolis Healthcare Ltd - 542650 - Compliance Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 40(9) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the Compliance Certificate dated April 13, 2022 issued by Ms. Rashmi Shah of M/S RM Shah & Co, Practicing Company Secretaries for the financial year ended March 31, 2022. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meeting Metropolis Healthcare Ltd - 542650 - Intimation For Voluntary Liquidation Of Dr. Ganesan'S Hitech Diagnostic Centre Private Limited ('Hitech'), Subsidiary Of The Company.
Dear Sir/Madam, With reference to our intimation dated February 11, 2022 having Reference No. MHL/ Sec&Legal/2021-22/71, Board of Directors of Hitech in their Meeting dated April 1, 2022 and the Members of Hitech in their Extra Ordinary General meeting held at a shorter notice on April 1, 2022 have accorded their approval for consolidation of the business of Hitech through voluntary liquidation process (subject to approval of the creditors of Hitech) and consequential appointment of the professional as required under the statute. Accordingly, subject to approval of the creditors of Hitech, the process shall be deemed to have been commenced from April 1, 2022. Pursuant to the voluntary liquidation, the entire business undertaking of Hitech, on a going concern basis, shall be distributed to the Company. Kindly take the above on record. Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Duru Shah Family Trust & PACs Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Duru Shah family Trust, Dr.Duru Shah & PACs Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 21, 2022 for Metz Advisory LLP Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 21, 2022 for Metz Advisory LLP Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meeting on March 17, 2022 Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meeting on March 15, 2022